GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 62 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $811,000 | -22.5% | 93,942 | 0.0% | 0.02% | -23.1% |
Q2 2019 | $1,047,000 | -22.6% | 93,942 | -7.7% | 0.03% | -23.5% |
Q1 2019 | $1,353,000 | -15.2% | 101,728 | -1.4% | 0.03% | -24.4% |
Q4 2018 | $1,595,000 | +88.3% | 103,224 | +73.5% | 0.04% | +125.0% |
Q3 2018 | $847,000 | – | 59,500 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,102,929 | $18,059,047,000 | 4.95% |
Svennilson Peter | 3,102,934 | $18,059,000 | 2.29% |
Casdin Capital, LLC | 2,270,000 | $13,211,000 | 1.40% |
FRAZIER MANAGEMENT LLC | 2,061,758 | $11,999,000 | 1.36% |
Redmile Group, LLC | 3,068,194 | $17,857,000 | 0.50% |
Alphabet Inc. | 929,022 | $5,407,000 | 0.36% |
Bleichroeder LP | 169,039 | $984,000 | 0.26% |
Leap Investments LP | 14,400 | $84,000 | 0.12% |
DAFNA Capital Management LLC | 50,000 | $291,000 | 0.12% |
Blackstone Inc. | 2,567,445 | $14,943,000 | 0.11% |